Abstract:624 Objectives: Idiopathic Parkinson’s disease (IPD) and atypical parkinsonian syndromes may have similar symptoms at the early disease stage. Positron emission tomography (PET) with 18F-FDG was shown to be be able to assess early neuronal dysfunction of taupathies. In the past decades, machine learning on metabolic patterns has been established for the differential diagnosis of parkinsonism [1]. Recent advancement of deep learning has brought record-breaking performance in many applications. This study examined whether this artificial intelligence tool is of value in an early differential diagnosis of parkinsonism. Methods: 257 patients with clinical features suspected for parkinsonism were subjected to an 18F-FDG PET imaging. After the imaging, these patients were followed up at least 1 year by blinded movement disorders specialists before a final clinical diagnosis of IPD (n=136), multiple system atrophy (MSA, n=91), and progressive supranuclear palsy (PSP, n=30) were made. To enable the fast establishment of deep neural network with limited computational power, a tensor factorization method [2] was employed to compress 3D brain imaging data to 2D images (supplemental figure). Then, A 4-layer convolutional neural network (CNN) was established to differentiate IPD, MSA and PSP based on the tensor-factorized 2D images. To enhance the performance, the CNN network was pretrained with a large database of brain FDG PET images. To this end, 1077 subjects of 41 various neurological diseases were included. Five fold cross validation was applied for the training and test of the pretrained CNN on the 257 parkinsonian patients. The classification CNN was implemented using python on Google9s TensorFlow platform and accelerated using NVIDIA Titan X graphics card. Results: After 85 iterations, all the folds for the test of the 2D CNN on tensor factorized images converges. The training took 3204 seconds. The test network has achieved 98.9% sensitivity, 90.0% specificity, 98.4% PPV and 95.0% NPV for the differentiation of PD, 98.8% sensitivity, 82.5% specificity, 96.1% PPV and 96.0% NPV for the classification of MSA and 87.1% sensitivity, 97.8% specificity, 96.1% PPV and 94.1% NPV for the classification of PSP. Conclusions: The preliminary test of deep learning on tensor factorized FDG PET images has demonstrated its ability to reach a cpmparable accuracy of state-of-the-art. Enlarging the database and further optimizing the deep neural network may enhance its potential in an early differential diagnosis of Parkinsonism. Physiological interpretation of the performance of the deep learning method needs to be investigated further.. Blind test on a separate group of parkinsonian patients is currently ongoing for in-depth assessment of the deep learning Methods: References: [1] Tang et al. Lancet Neuro 2010 [2] Li et al. MICCAI 2017 Research support: The study was supported by grants (No.81771483, No. 81671239, No. 81401135 and No. 81361120393) from the National Natural Science Foundation of China.

Comparison of Anatomical and Diffusion MRI for Detecting Parkinson's Disease Using Deep Convolutional Neural Network.

A Parkinson's Disease-Related Nuclei Segmentation Network Based on Cnn-Transformer Interleaved Encoder with Feature Fusion

Contribution and Clinical Significance of 3D and 2D Deep Learning and Radimoics Features Based on MR-T1W Images in Joint Diagnosis of Parkinson's Disease

Contrastive Machine Learning Reveals Parkinson’s Disease Specific Features Associated with Disease Severity and Progression

Deep Learning on 18F-FDG PET Imaging for Differential Diagnosis of Parkinsonian Syndromes

Exploiting macro- and micro-structural brain changes for improved Parkinson’s disease classification from MRI data

Deep Learning Based Diagnosis of Parkinson's Disease Using Diffusion Magnetic Resonance Imaging.

An adaptive weighted attention-enhanced deep convolutional neural network for classification of MRI images of Parkinson's disease

Use of Magnetic Resonance Imaging and Artificial Intelligence in Studies of Diagnosis of Parkinson’s Disease

Deep Learning Models for Discrimination of Parkinson's Disease and Multiple System Atrophy on Brain Magnetic Resonance Imaging

PDDS: A Software for the Early Diagnosis of Parkinson’s Disease from MRI and DatScan Images using Detection and Segmentation Algorithms

Comparative Validation of AI and non-AI Methods in MRI Volumetry to Diagnose Parkinsonian Syndromes

Parkinson’s disease: deep learning with a parameter-weighted structural connectome matrix for diagnosis and neural circuit disorder investigation

2D and 3D Deep Learning Models for MRI-based Parkinson's Disease Classification: A Comparative Analysis of Convolutional Kolmogorov-Arnold Networks, Convolutional Neural Networks, and Graph Convolutional Networks

Contrastive machine learning reveals Parkinson's disease specific features associated with disease severity and progression

Diagnosis of Parkinson's Disease Based on Feature Fusion on T2 MRI Images.

Deep learning classification of MRI differentiates brain changes in genetic and idiopathic Parkinson's disease

A Light-weight CNN Model for Efficient Parkinson's Disease Diagnostics

A deep 1-D CNN learning approach with data augmentation for classification of Parkinson's disease and scans without evidence of dopamine deficit (SWEDD)

Comparison of deep learning architectures for predicting amyloid positivity in Alzheimer's disease, mild cognitive impairment, and healthy aging, from T1-weighted brain structural MRI

A 3d Deep Residual Convolutional Neural Network For Differential Diagnosis Of Parkinsonian Syndromes On F-18-Fdg Pet Images